Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Dr. Gary PatouIndependent Director | -1,32k | 70,25k | Automatic Disposition | 53,14 | 29,80k | -4,25% |
| 2026-06-05 | Dr. Gillian M. CannonIndependent Director | -1,19k | 63,24k | Automatic Disposition | 53,14 | 1,46k | -44,99% |
| 2026-06-01 | Mr. Justin D. GoverIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 2,65k | - |
| 2026-06-01 | Dr. Gary PatouIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 31,12k | 9,29% |
| 2026-06-01 | Mr. C. Patrick MachadoIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 2,65k | - |
| 2026-06-01 | Dr. Elizabeth A. GarofaloIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 2,65k | - |
| 2026-06-01 | Mr. Steven R. GannonIndependent Director | -1,42k | 75,63k | Derivative Exercise and Sale | 53,41 | 11,87k | - |
| 2026-06-01 | Mr. Steven R. GannonIndependent Director | 1,23k | 0,00 | Derivative Exercise and Retained Stock | - | 11,87k | 11,55% |
| 2026-06-01 | Dr. Gillian M. CannonIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 2,65k | - |
| 2026-06-01 | Ms. Dawn A. SvoronosIndependent Chairman | -1,42k | 75,63k | Derivative Exercise and Sale | 53,41 | 26,23k | - |
| 2026-06-01 | Ms. Dawn A. SvoronosIndependent Chairman | 1,23k | 0,00 | Derivative Exercise and Retained Stock | - | 26,23k | 4,92% |
| 2026-05-12 | Mr. Steven R. GannonIndependent Director | 3,50k | 25,83k | Derivative Exercise and Retained Stock | 7,38 | 10,64k | 49,01% |
| 2026-03-12 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | 2,41k | 0,00 | Derivative Exercise and Retained Stock | - | 7,30k | 49,21% |
| 2026-03-12 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | -1,34k | 74,11k | Derivative Exercise and Sale | 55,23 | 7,30k | - |
| 2026-03-12 | Dr. Christopher John KenneyChief Medical Officer | 2,34k | 0,00 | Derivative Exercise and Retained Stock | - | 7,07k | 49,48% |
| 2026-03-12 | Dr. Christopher John KenneyChief Medical Officer | -1,41k | 77,87k | Derivative Exercise and Sale | 55,23 | 7,07k | - |
| 2026-03-12 | Mr. Ian C. MortimerPresident, CEO & Director | 5,19k | 0,00 | Derivative Exercise and Retained Stock | - | 34,22k | 17,88% |
| 2026-03-12 | Mr. Ian C. MortimerPresident, CEO & Director | -7,31k | 403,58k | Derivative Exercise and Sale | 55,23 | 34,22k | - |
| 2026-03-09 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | 4,89k | 0,00 | Derivative Exercise and Retained Stock | - | 4,89k | - |
| 2026-03-09 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | -2,61k | 156,70k | Derivative Exercise and Sale | 60,11 | 4,89k | - |
| 2026-03-09 | Dr. Christopher John KenneyChief Medical Officer | 4,73k | 0,00 | Derivative Exercise and Retained Stock | - | 4,73k | - |
| 2026-03-09 | Dr. Christopher John KenneyChief Medical Officer | -2,77k | 166,56k | Derivative Exercise and Sale | 60,11 | 4,73k | - |
| 2026-03-09 | Mr. Ian C. MortimerPresident, CEO & Director | 20,00k | 0,00 | Derivative Exercise and Retained Stock | - | 29,03k | 221,46% |
| 2026-03-09 | Mr. Ian C. MortimerPresident, CEO & Director | -270,00k | 14,47M | Derivative Exercise and Sale | 3,10 - 62,06 | 29,03k | - |
| 2026-03-10 | Mr. Ian C. MortimerPresident, CEO & Director | -11,27k | 677,36k | Automatic Disposition | 60,11 | 29,03k | -27,96% |
| 2026-01-02 | Mr. Ian C. MortimerPresident, CEO & Director | -40,00k | 1,48M | Derivative Exercise and Sale | 7,49 - 44,93 | 20,30k | - |
| 2025-12-05 | Mr. Ian C. MortimerPresident, CEO & Director | -25,21k | 1,14M | Automatic Disposition | 45,03 - 46,32 | 20,30k | -55,39% |
| 2025-11-28 | Mr. Ian C. MortimerPresident, CEO & Director | -97,00 | 4,37k | Automatic Disposition | 45,01 | 45,51k | -0,21% |
| 2025-10-15 | Mr. Thomas Patrick KellyCFO | 225,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 29,87 | 225,00k | - |
| 2025-10-15 | Mr. Thomas Patrick KellyCFO | 30,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 30,00k | - |
| 2025-10-01 | Mr. Ian C. MortimerPresident, CEO & Director | -25,00k | 1,00M | Verkauf | 40,16 | 45,60k | -35,41% |
| 2025-10-01 | Mr. Ian C. MortimerPresident, CEO & Director | 25,00k | 192,25k | Derivative Exercise and Retained Stock | 7,69 | 45,60k | 121,35% |
| 2025-10-01 | Mr. Ian C. MortimerPresident, CEO & Director | -25,00k | 811,75k | Derivative Exercise and Sale | 7,69 - 40,16 | 45,60k | - |
| 2025-06-23 | Mr. Darren S. ClineChief Commercial Officer | 185,80k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 22,93 | 185,80k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
